| Tag | Content |
|---|
EnhancerAtlas ID | HS034-10947 |
Organism | Homo sapiens |
Tissue/cell | ECC-1 |
Coordinate | chr16:11408890-11410910 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| IRF2 | MA0051.1 | chr16:11410587-11410605 | GGAATGTGAAACCATTAT | + | 6.1 | | STAT3 | MA0144.2 | chr16:11410813-11410824 | CTTCCCAGAAA | - | 6.02 | | ZNF263 | MA0528.1 | chr16:11409439-11409460 | GCCCTCCCCTCCCCCTCCCCA | - | 6.01 | | ZNF263 | MA0528.1 | chr16:11409462-11409483 | TCCTCCATACACTCATCCTCC | - | 6.05 | | ZNF263 | MA0528.1 | chr16:11409447-11409468 | CTCCCCCTCCCCATCTCCTCC | - | 6.39 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_33035 | chr16:11409653-11411190 | H1 | | SE_62053 | chr16:11386770-11424077 | Toledo | | SE_68718 | chr16:11405593-11411409 | H9 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr16 | 11409360 | 11409770 | | chr16 | 11409864 | 11410719 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH16I011306 | chr16 | 11400381 | 11411109 |
|
Enhancer Sequence | CCATCAAGCT GCACATTTAA GATGAGTGCA CTTGTCTGGT CTGAAGGTAG TAAGTTATCT 60
CAGTCAATTG TTCACAGGCA GTTACAGATC CAACTCCTCA TTTTACTCTT TCCCCTTTCT 120
CATGACTGCA CTTGACTAGT CTAAAAGCCA AAAAGGGCTG GTTGCGGTGG CTCACGCCTG 180
TAATCTCAAC ACTTTGGGAG GCCGAGGTGG GTGGATCATT TGAGGTTAGG CGTTCGAGAC 240
CAGCCTGGCC AACACAGCGA AACCCCATCT CTACTAAAAA TAAAAAGTAA TTAGCCGGGC 300
GTGGTGGCAC GCGCCTGTAA CCTCAGCTAC TGGGGAGGCT GAGGGAGGAG AATTGCTTGA 360
ACCCGGTGGC AGAGACTGAC TGAGCCAAGA TTGTGCCACT GCACTCCAGC CTGGGCGACA 420
GAGCAGGACT CCACCTCAAA AAATAAAAAT AAAAAAATAT CCAGCCCAAG AAGGGCCGCA 480
GGATGAACTC AGAATGGTTA ATGAACCATG AGCCAAGTGG TGAGTACTGG CCACCCACGG 540
TGCCCCTTAG CCCTCCCCTC CCCCTCCCCA TCTCCTCCAT ACACTCATCC TCCAACACGC 600
CCTCCTGGTC CAGGTGCTAG GGCGGGATGC AGGCGCCTCA CATTCCAGCA GGGCAGCCGT 660
GTCTGTCTCA GGAAATGCGT GTGGTCTCCA GCTCTGGCCG CCAGGAGACA AAGCCACCCG 720
CTTTGTTCCT TGGCCCCCAG CAGGAGGGGG AAGGGGAGAA TTTCCTTAGG AGAGGTTCCA 780
AGAAGAGGAA TTACTGCTTC AAAGGGAGTG CACCATTTCA GGCGGCTGAG AGCTGCTGCG 840
CCGCCTTCCA GAAGGGGCCC GGCACCCCTT ATTGTTCCCA GCATGTGGGT CCCGGCTGGG 900
TCTGCCTTAG GGCCCACTCT CCTGTCACCT GCTCCCTCTC TTGCAGTTGG CGACCCCTGG 960
GGTCTCCTCT GAGTGGCCTC TGCCCTCAGT TGCCCACCCA CCCTGCCCCC TGTCCTTGCT 1020
GTCCTCTTGG TGGGGATGGA TAGCCCCTTC TTTTCCCCTC CCCTACTGCC CCACTGCCTC 1080
ACTCTCGTCA TTTATTTCCT CACTTAGGTC CTTGTCCCTG AAGGGCCATG GAGCTAAGTG 1140
ACCAGCGTGC CTCTCTGGGT CCCGTGTGTG TGGTAGGAAT CTTCACACTG CCTTGCTGTG 1200
ACCGTGGGCC ATCGCATCAC CTCCCTGTGC CTTGGTTTCC TGGCCTCTAA AGACTGACCT 1260
TAAGGGGTTG TTTGTAAGGA TGAAGGCACA AATGCAAGCC AAGTCCTTAG AATTCTCAGC 1320
ACATAGCAAG TGCTCAATGA ACCGCCTGGC TGCTGTTCGC TGGGGACACA GTCTTTTGCT 1380
CTCTGGATGT CTGACCGTGC CCTGTCCCTG CCTCACAGGG CCATCCATCA GTGCTGGTGA 1440
GCTGAGCTCA GCTGACAAGC CAGCCTGGCA CGGAGCGCTG CCCCTCCTGC TGGTCCCAGA 1500
TCCGTTCTGT CCGGAGGAGA ATTTCTTATC CCCAGGAGAT GCCTGGCCTC GTTAGGAGCC 1560
TCCTCACCCG CCCGCCCGCA CCAACCCTCT GACTCCCTCC ACCTCACCGC CTGGGAACAA 1620
CAGGAAGAGA GCAGGACAGC AGCAGAAAGG AGTGCTGCTT ATGTGGCTCT TCTCAGAATC 1680
AGGAGGCTCC CAGGCCAGGA ATGTGAAACC ATTATGCAGA TGAAGAAGAT GAAGCCCGAG 1740
AGGTTATGAA ACAGACCCAA GTGGGCTCGC TCTTCAGTCT CGGCATAAGG AATCCGGAAC 1800
CTGGGCCCGT GTCCGGAACT GCTGTGCCCA GGCAGCTTGC CTGGAAATCA GGTAGCGTGG 1860
GGGGACCCCA AAATCCCCCT GTGACAGACC ACGAATCTGC CGTGTTTGTG CACCTCTGTT 1920
TTGCTTCCCA GAAACGAAAC TTTGGCAACT GGAGAGGGAT GGAGTGGGGC GGGTGGGGTA 1980
CAGCAAGATC GGGAAACAGC ACCGTCCTCA AATGCCTGCA 2020
|
